Footnotes * Both authors contributed equally to this work. This work was funded by the NIH grant P30 CA 14089, supported by the San Pedro Guild and the Dhont Foundation.
A large proportion

of esophageal cancers present initially in an advanced stage (1). Extra-nodal metastases are seen in 20% of the patients (2),(3), Inhibitors,research,lifescience,medical the liver and lungs are the more common places (2),(3). Cutaneous metastases (CM) are rarely reported (4)-(12). We report two cases of skin metastases from esophageal cancer. Case report Case 1 A 68-year-old male patient presented with dysphagia for 3 months. Upper endoscopy and computerized tomography disclosed a mid-thoracic esophageal squamous cell selleck chemicals carcinoma with extension to the airway rendering the tumor inoperable. No extra-nodal metastasis was noticed. The

patient presented concomitantly with two red non-painful fast-growing nodules with ulceration in the nose and neck (Fig 1). Biopsy disclosed a squamous cell carcinoma considered a metastasis due Inhibitors,research,lifescience,medical to the atypical and Inhibitors,research,lifescience,medical rapid grow for a primary skin lesion since histology cannot differentiate both conditions. The patient was sent to oncologic clinical treatment. Figure 1. Cutaneous metastases from an esophageal squamous cell carcinoma Case 2 A 73- year-old male patient presented with skin lesion 2 years after a total gastrectomy and distal esophagectomy

for esophagogastric junction cancer followed by adjuvant chemotherapy Inhibitors,research,lifescience,medical (T3N1M0). Physical examination revealed an extensive area of the abdomen covered by red plaques (Fig 2). Biopsy disclosed an adenocarcinoma. No other site of recurrence was detected. Patient was referred to clinical oncologic treatment. Figure 2. Cutaneous metastases from Inhibitors,research,lifescience,medical an esophagogastric junction adenocarcinoma Discussion The skin is an uncommon site of metastases. CM was found in only 10% of a large series with over 4000 cases of metastatic cancer (4). Skin metastases from esophageal cancer affect less than 1% of the cases (9),(13). It may originate from squamous cell carcinoma as well as from adenocarcinoma (4)-(12). Skin metastases (-)-p-Bromotetramisole Oxalate from esophagogastric junction tumors with similar characteristics to gastric cancer have also been described (7) as for that matter skin metastases from gastric tumors have also been rarely reported (9),(14),(15). A myriad of presentations may be seen, however, nodules are the most common form (5),(8),(10). Any location in the body may be affected (4). The presence of CM denotes an advanced disease. Survival is dismal with an average of 4 months (4). Surgeons must be aware that cutaneous lesions may represent the first sign of systemic spreading of esophageal carcinoma (4),(9). Footnotes No potential conflict of interest.